Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Approved pharmaceutical formulations exist under separate distribution channels for type 2 diabetes (approved 2022), chronic weight management (approved 2023), and obstructive sleep apnea in adults with obesity (approved 2024)
Sleep quality tracking is valuable for anyone with known or suspected sleep apnea
.png)
Keep vials upright in a clean secondary container to catch any leakage
GLP-1 medications work through incretin hormone mimicry
US$ 24.90
US$ 24.28
US$ 21.58
US$ 25.08
US$ 27.63
US$ 21.52
